Clinical Trial Update: Study of Nilotinib in Metastatic Melanoma With KIT Aberrations [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study of nilotinib in patients with metastatic melanoma harboring KIT aberrations. The trial is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Metastatic Melanoma With KIT Aberration | Phase 2 | Status: COMPLETED